Maximilian F. Konig is an assistant professor of medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. His research interests include immunoengineering and elucidating mechanisms underlying the initiation and progression of autoimmune diseases. Konig’s lab develops novel precision cellular and protein-based immunotherapies to treatment autoimmune and rheumatic diseases, aiming to selectively eliminate autoreactive immune cells while preserving protective immune responses. Such therapies have the potential to treat and prevent autoimmune disease without increasing the risk of infection, a primary cause of death in patients treated with current immunosuppressive drugs. His lab also employs similar engineering approaches to develop cellular therapies for hard-to-treat cancers. Konig received his medical degree from Charité – Universitätsmedizin Berlin and Humboldt-Universität zu Berlin and completed his residency training in internal medicine in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School. He completed fellowship training in clinical and molecular rheumatology at Johns Hopkins Hospital and received postdoctoral research training in the Division of Rheumatology and the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins.